BMJ Case Reports. Vol. 16. 2023. e253081 p..
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
Currently licensed human papillomavirus (HPV) vaccines are very effective against cervical cancer and pre-cancer and probably also effective against five additional HPV-related cancers with no available screening strategies.[1][1] Antibodies triggered by the vaccine are different from antibodies
Authors
Kamani M.O. 3, 4 , Kyrgiou Maria 5, 6, 7, 8 , Joura Elmar 9, 10 , Zapardiel Ignacio 11, 12 , Grigore Mihaela 3, 13 , Arbyn Marc 14, 15, 16, 17 , Preti Mario 18, 19 , Planchamp François , Gultekin Murat 3, 4
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Issue number
4
Language
English
Pages
462-464
State
Published
Volume
33
Year
2023
Organizations
- 1 Department of Obstetrics and Gynecology
- 2 Hacettepe University Faculty of Medicine
- 3 IRDB, Department of MDR – Surgery & Cancer
- 4 Imperial College Healthcare NHS Trust
- 5 Imperial College London
- 6 West London Gynaecological Cancer Centre
- 7 Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Center
- 8 Medical University of Vienna
- 9 Gynecologic Oncology
- 10 La Paz University Hospital
- 11 Grigore T Popa University of Medicine and Pharmacy Faculty of Medicine
- 12 Belgian Cancer Centre Sciensano
- 13 Department of Human Structure and Repair
- 14 Ghent University Faculty of Medicine and Health Sciences
- 15 Unit of Cancer Epidemiology
- 16 Department of Obstetrics and Gynaecology
- 17 Università degli Studi di Torino
- 18 Clinical Research Unit
- 19 Institut Bergonie
Share
Other records
Translational Andrology and Urology. Vol. 12. 2023. P.. 487-496